R&D Systems™ Recombinant Human CD44 Fc Chimera Protein

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

The Recombinant Human CD44 Fc Chimera Protein is derived from NS0. The Recombinant Human CD44 Fc Chimera Protein has been validated for the following applications: Binding Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 960
• Molecular Weight (g/mol): Observed M.W.: Observed M.W.: 72-86 kDa, reducing conditions
• Name: CD44 Fc Chimera
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human CD44 protein, (N-terminus) Human CD44 (Gln21-Pro220) Accession # P16070 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.